OBJECTIVES: To determine the association between invasive cervical cancer (ICC) and HIV infection in Kenyan women. STUDY DESIGN: Case-control, with ICC patients as cases, and women with uterine fibroids as controls. METHODS: Medical and socio-demographic data were collected from 367 ICC patients, and 226 women with fibroids. After informed consent, HIV testing was done. RESULTS: ICC patients were older than fibroid patients (48 versus 41 years; P < 0.001), with an HIV seroprevalence of 15% and 12% respectively (P > 0.05). However, cases younger than 35 years were 2.6-times more likely to be HIV positive than controls of similar age [35% versus 17%; odds ratio (OR), 2.6; P = 0.043]. ICC HIV-seropositive patients were, on average, 10 years younger than HIV-seronegative patients (40 versus 50 years; P < 0.001). Eighty per cent of HIV-seropositive and 77% of HIV-seronegative ICC patients were in FIGO stage IIb or above. However, the odds of having poorly differentiated tumours was three times higher for HIV-seropositive than for HIV-seronegative ICC patients (77% versus 52%; OR, 3.1; P = 0.038) after adjusting for histological cell type and clinical stage. Mean CD4 cell count was 833 x 10(6) cells/l in ICC and 1025 x 10(6) cells/l in fibroid patients (P = 0.001). CONCLUSION: Young women with ICC were more often HIV infected than women with fibroids of the same age groups. HIV infection was associated with poor histological differentiation of the tumours. These findings suggest an accelerated clinical progression of premalignant cervical lesions to ICC in HIV-infected women.
OBJECTIVES: To determine the association between invasive cervical cancer (ICC) and HIV infection in Kenyan women. STUDY DESIGN: Case-control, with ICC patients as cases, and women with uterine fibroids as controls. METHODS: Medical and socio-demographic data were collected from 367 ICC patients, and 226 women with fibroids. After informed consent, HIV testing was done. RESULTS: ICC patients were older than fibroid patients (48 versus 41 years; P < 0.001), with an HIV seroprevalence of 15% and 12% respectively (P > 0.05). However, cases younger than 35 years were 2.6-times more likely to be HIV positive than controls of similar age [35% versus 17%; odds ratio (OR), 2.6; P = 0.043]. ICC HIV-seropositivepatients were, on average, 10 years younger than HIV-seronegative patients (40 versus 50 years; P < 0.001). Eighty per cent of HIV-seropositive and 77% of HIV-seronegative ICC patients were in FIGO stage IIb or above. However, the odds of having poorly differentiated tumours was three times higher for HIV-seropositive than for HIV-seronegative ICC patients (77% versus 52%; OR, 3.1; P = 0.038) after adjusting for histological cell type and clinical stage. Mean CD4 cell count was 833 x 10(6) cells/l in ICC and 1025 x 10(6) cells/l in fibroid patients (P = 0.001). CONCLUSION: Young women with ICC were more often HIV infected than women with fibroids of the same age groups. HIV infection was associated with poor histological differentiation of the tumours. These findings suggest an accelerated clinical progression of premalignant cervical lesions to ICC in HIV-infectedwomen.
Authors: Paul H M Smits; Remco Bakker; Eefje Jong; Jan Willem Mulder; Pieter L Meenhorst; Bernhard Kleter; Leen-Jan van Doorn; Wim G V Quint Journal: J Clin Microbiol Date: 2005-12 Impact factor: 5.948
Authors: Heather L White; Chishimba Mulambia; Moses Sinkala; Mulindi H Mwanahamuntu; Groesbeck P Parham; Linda Moneyham; Diane M Grimley; Eric Chamot Journal: Soc Sci Med Date: 2012-03-07 Impact factor: 4.634
Authors: Chemtai Mungo; Craig R Cohen; May Maloba; Elizabeth A Bukusi; Megan J Huchko Journal: Int J Gynaecol Obstet Date: 2013-09-10 Impact factor: 3.561
Authors: Georgette Adjorlolo-Johnson; Elizabeth R Unger; Edith Boni-Ouattara; Kadidiata Touré-Coulibaly; Chantal Maurice; Suzanne D Vernon; Marcel Sissoko; Alan E Greenberg; Stefan Z Wiktor; Terence L Chorba Journal: BMC Infect Dis Date: 2010-08-17 Impact factor: 3.090
Authors: Sharon Kapambwe; Vikrant V Sahasrabuddhe; Meridith Blevins; Mulindi H Mwanahamuntu; Victor Mudenda; Bryan E Shepherd; Carla J Chibwesha; Krista S Pfaendler; Michael L Hicks; Sten H Vermund; Jeffrey S A Stringer; Groesbeck P Parham Journal: J Acquir Immune Defic Syndr Date: 2015-09-01 Impact factor: 3.731
Authors: Mario Jesus Trejo; Kennedy Lishimpi; Mulele Kalima; Catherine K Mwaba; Lewis Banda; Alick Chuba; Eslone Chama; Susan C Msadabwe; Melanie L Bell; Robin B Harris; Elizabeth Jacobs; Amr Soliman Journal: Int J Gynecol Cancer Date: 2020-03-21 Impact factor: 3.437
Authors: Bettina Moulin Coelho Lima; Jonathan E Golub; Adriana Tonani Mattos; Luciana Bueno de Freitas; Liliana Cruz Spano; Angélica Espinosa Miranda Journal: J Int Assoc Physicians AIDS Care (Chic) Date: 2009-08-31
Authors: Brandon L Guthrie; Anne F Rositch; Joy Alison Cooper; Carey Farquhar; Rose Bosire; Robert Choi; James Kiarie; Jennifer S Smith Journal: Sex Transm Infect Date: 2020-01-09 Impact factor: 3.519
Authors: Innocent O Maranga; Lynne Hampson; Anthony W Oliver; Xiaotong He; Peter Gichangi; Farzana Rana; Anselmy Opiyo; Ian N Hampson Journal: Open Virol J Date: 2013-02-25